Cav1.2 has targets for CaMKII phosphorylation in its structure as well as other regulatory subunits of the channels [50], it is also activated by the βAR pathway [51] and the inhibition of CaMKII on heart failure has been proposed as a therapeutic strategy [40]. The gene discussed is ADRB2; the disease is heart failure.